TP53 and mesothelioma: Knockout (KO) mouse models with heterozygous mutations in Bap1, CDKN2A, neurofibromin 2 (Nf2), or p53 have been used to study the effect of genetic alterations on asbestos-induced mesothelioma susceptibility (103–112).